Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review

被引:18
|
作者
Mauriello, Claudio [1 ]
Napolitano, Salvatore [3 ]
Gambardella, Claudio [1 ]
Candela, Giancarlo [1 ]
De Vita, Ferdinando [2 ]
Orditura, Michele [2 ]
Sciascia, Valerio [1 ]
Tartaglia, Ernesto [1 ]
Lanza, Michele [1 ]
Santini, Luigi [1 ]
Conzo, Giovanni [1 ]
机构
[1] Univ Naples 2, Sch Med, Dept Anaesthesiol Surg & Emergency Sci, Unit Gen & Oncol Surg, I-80131 Naples, Italy
[2] Univ Naples 2, Sch Med, Dept Clin & Expt Med, Div Oncol, I-80131 Naples, Italy
[3] Minist Def, Italian Air Force Med Corps, Rome, Italy
关键词
Pancreatic neuroendocrine tumors; Conservative management; Parenchyma-sparing resections; Intraoperative ultrasonography; Thompson procedure; MULTIPLE-ENDOCRINE-NEOPLASIA; HIPPEL-LINDAU-DISEASE; SURGICAL-MANAGEMENT; INJECTION TEST; SURGERY; TYPE-1; GUIDELINES; CANCER;
D O I
10.1016/j.ijsu.2015.04.089
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Pancreatic neuroendocrine tumors (pNETs) are uncommon entities. pNETs are often small, slow growing, clinically silent neoplasms. However, they have an almost unpredictable biological behaviour with a not negligible malignant potential. Surgery still represents the treatment of choice, but the high morbidity associated to the enucleation or the formal pancreatectomy should be considered in the decision of the proper treatment. Management of these neoplasms is still debated, and indications for a conservative observational approach and for parenchyma sparing resections are not yet standardized. Method: We review the state of art on the indications for the conservative management of pNETs. Searches on MEDLINE database were performed to identify articles reporting prognostic systems, biochemical screening, observational management, medical treatment and surgical strategies for pNETs. Discussion: Currently, an accurate 'wait-and-see' policy is recommended by the European Neuroendocrine Tumor Society (ENETS) only for non-functioning pNETs (NF-pNETs) <2 cm. A biochemical screening, based on sampling of serum levels of pancreatic polypeptide (PP) and chromogranin A, can address to early conservative surgery for MEN-1 associated NF-pNETs <2 cm to prevent their malignant transformation. The subtotal (80%) distal pancreatectomy first proposed by Thompson, often with the enucleation of possible pancreatic head tumors, still represents a good compromise between oncological radicality and prevention of pancreatic endocrine/exocrine insufficiency caused by standard radical resections for the treatment of inherited syndromes associated with NF-pNETs >2 cm and symptomatic F-pNETs of any size. Conclusion: More studies are needed to further clarify and predict the biologic behaviour of pNETs and increase the indications for conservative observational management and parenchyma sparing pancreas resections. (C) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S10 / S14
页数:5
相关论文
共 50 条
  • [1] Parenchyma-Sparing Resections for Pancreatic Neuroendocrine Tumors
    Rim Cherif
    Sébastien Gaujoux
    Anne Couvelard
    Safi Dokmak
    Marie-Pierre Vuillerme
    Philippe Ruszniewski
    Jacques Belghiti
    Alain Sauvanet
    Journal of Gastrointestinal Surgery, 2012, 16 : 2045 - 2055
  • [2] Parenchyma-Sparing Resections for Pancreatic Neuroendocrine Tumors
    Cherif, Rim
    Gaujoux, Sebastien
    Couvelard, Anne
    Dokmak, Safi
    Vuillerme, Marie-Pierre
    Ruszniewski, Philippe
    Belghiti, Jacques
    Sauvanet, Alain
    JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (11) : 2045 - 2055
  • [3] Parenchyma-sparing pancreatectomies for pancreatic neuroendocrine tumors
    Cherif, Rim
    Gaujoux, Sebastien
    Cros, Jerome
    Ruszniewski, Philippe
    Sauvanet, Alain
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (03) : 217 - 227
  • [4] Parenchyma-sparing resections for pancreatic neoplasms
    Crippa, Stefano
    Boninsegna, Letizia
    Partelli, Stefano
    Falconi, Massimo
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2010, 17 (06) : 782 - 787
  • [5] Parenchyma-Sparing Pancreatic Resections: With or Without a Pancreaticojejunostomy?
    Wronski, Marek
    Cebulski, Wlodzimierz
    Krasnodebski, Ireneusz W.
    Slodkowski, Maciej
    HEPATO-GASTROENTEROLOGY, 2014, 61 (132) : 1113 - 1117
  • [6] Parenchyma-sparing liver resections
    Torzilli, Guido
    McCormack, Lucas
    Pawlik, Timothy
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 82 : 192 - 197
  • [7] Parenchyma-sparing surgery for pancreatic endocrine tumors
    Fara Uccelli
    F. Gavazzi
    G. Capretti
    M. Virdis
    M. Montorsi
    A. Zerbi
    Updates in Surgery, 2016, 68 : 313 - 319
  • [8] Parenchyma-sparing surgery for pancreatic endocrine tumors
    Uccelli, Fara
    Gavazzi, F.
    Capretti, G.
    Virdis, M.
    Montorsi, M.
    Zerbi, A.
    UPDATES IN SURGERY, 2016, 68 (03) : 313 - 319
  • [9] One Hundred Thirty Resections for Pancreatic Neuroendocrine Tumor: Evaluating the Impact of Minimally Invasive and Parenchyma-Sparing Techniques
    DiNorcia, Joseph
    Lee, Minna K.
    Reavey, Patrick L.
    Genkinger, Jeanine M.
    Lee, James A.
    Schrope, Beth A.
    Chabot, John A.
    Allendorf, John D.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (10) : 1536 - 1545
  • [10] One Hundred Thirty Resections for Pancreatic Neuroendocrine Tumor: Evaluating the Impact of Minimally Invasive and Parenchyma-Sparing Techniques
    Joseph DiNorcia
    Minna K. Lee
    Patrick L. Reavey
    Jeanine M. Genkinger
    James A. Lee
    Beth A. Schrope
    John A. Chabot
    John D. Allendorf
    Journal of Gastrointestinal Surgery, 2010, 14 : 1536 - 1546